The use of PET/CT and PET/MRI with the application of 18F-fluoroestradiol in the imaging of breast carcinoma
Authors:
- Jiří FerdaJFJiří Ferda
- Eva FerdováEFEva Ferdová
- Táňa BarákováTBTáňa Baráková
- Marika LooseováMLMarika Looseová
- Martina OdvodyMOMartina Odvody
- Samuel VokurkaSVSamuel Vokurka
Open Access
- 22 April 2025
- journal article
- Published by Galen, spol. s r.o. in Česká radiologie
- Vol. 79 (1) , 15-24
Abstract
C?l: 18F-fluorestradiol je nov? radiofarmakum, kter? lze pou??t p?i zobrazov?n? karcinomu prsu, indikace v klinick?ch postupech je?t? nemaj? sv? pevn? m?sto, proto je c?lem studie posoudit klinick? v?znam zobrazen? karcinomu prsu estrogen-pozi... C?l: 18F-fluorestradiol je nov? radiofarmakum, kter? lze pou??t p?i zobrazov?n? karcinomu prsu, indikace v klinick?ch postupech je?t? nemaj? sv? pevn? m?sto, proto je c?lem studie posoudit klinick? v?znam zobrazen? karcinomu prsu estrogen-pozi...Keywords
This publication has 9 references indexed in Scilit:
- [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesEuropean Journal of Radiology, 2024
- Update on 18F-FluoroestradiolSeminars in Nuclear Medicine, 2024
- Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PETAnnals of Oncology, 2024
- Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-18F-Fluoro-17β-FluoroestradiolJournal of Nuclear Medicine, 2023
- 18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysisRevista da Associação Médica Brasileira, 2023
- 16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast CancerSeminars in Nuclear Medicine, 2022
- Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancerNuclear Medicine and Biology, 2011
- Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast CancerClinical Cancer Research, 2011